US Stock MarketDetailed Quotes

Legend Biotech (LEGN)

Watchlist
  • 23.900
  • -0.090-0.38%
Close Apr 24 16:00 ET
  • 23.900
  • 0.0000.00%
Post 20:01 ET
4.42BMarket Cap-14.75P/E (TTM)

Legend Biotech (LEGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
64.02%1.03B
64.21%306.38M
69.99%272.33M
36.74%255.06M
107.52%195.05M
120.03%627.3M
134.93%186.58M
66.86%160.21M
154.36%186.52M
158.67%93.99M
Operating revenue
65.64%1.03B
64.34%306.19M
70.28%272.31M
38.54%255.06M
115.04%194.96M
117.89%621M
134.48%186.31M
66.60%159.92M
151.27%184.1M
149.90%90.66M
Cost of revenue
73.96%408.1M
66.97%123.46M
107.87%115.31M
94.23%97.99M
30.33%71.34M
62.69%234.6M
127.96%73.94M
27.58%55.47M
54.42%50.45M
53.71%54.74M
Gross profit
58.09%620.8M
62.39%182.92M
49.92%157.02M
15.43%157.07M
215.17%123.71M
178.71%392.7M
139.74%112.64M
99.37%104.74M
234.67%136.07M
5,329.05%39.25M
Operating expense
7.85%757.3M
6.03%203.52M
14.50%200.48M
0.51%178.95M
10.97%174.36M
4.96%702.2M
-24.86%191.95M
20.85%175.09M
23.36%178.04M
26.36%157.12M
Selling and administrative expenses
20.15%341.6M
21.68%101.19M
9.75%87.33M
23.28%80.65M
28.99%72.43M
41.44%284.3M
33.15%83.16M
61.72%79.57M
33.01%65.42M
39.82%56.15M
-Selling and marketing expense
39.53%205.8M
31.11%64.17M
18.83%52.61M
59.84%48.05M
69.13%40.97M
56.58%147.5M
45.15%48.94M
109.83%44.27M
40.29%30.06M
34.92%24.22M
-General and administrative expense
-0.73%135.8M
8.19%37.02M
-1.64%34.72M
-7.80%32.59M
-1.46%31.46M
28.09%136.8M
19.07%34.22M
25.60%35.3M
27.38%35.35M
43.79%31.93M
Research and development costs
0.29%414.7M
-2.93%101.33M
18.45%113.15M
-12.72%98.3M
0.95%101.92M
8.19%413.5M
-1.21%104.39M
-0.35%95.52M
17.57%112.63M
18.94%100.96M
Other operating expenses
-77.27%1M
----
----
----
----
-94.87%4.4M
-100.64%-563K
-73.86%-306K
34.58%-420K
13.24%-616K
Operating profit
55.90%-136.5M
74.02%-20.6M
38.24%-43.45M
47.87%-21.88M
57.03%-50.65M
41.39%-309.5M
61.96%-79.31M
23.81%-70.36M
59.52%-41.97M
4.65%-117.86M
Net non-operating interest income expense
-52.78%18.7M
-71.00%2.47M
-63.82%4.03M
-54.94%5.21M
-16.68%7M
21.10%39.6M
-25.90%8.51M
-12.70%11.13M
69.45%11.57M
411.27%8.4M
Non-operating interest income
-34.48%40.1M
-41.76%7.95M
-41.91%9.66M
-38.81%10.43M
-13.08%12.06M
12.29%61.2M
-21.17%13.65M
-9.72%16.63M
41.96%17.05M
105.33%13.87M
Non-operating interest expense
-0.93%21.4M
6.70%5.48M
2.40%5.64M
-4.78%5.22M
-7.56%5.06M
-0.92%21.6M
-11.83%5.14M
-3.03%5.5M
5.77%5.48M
7.08%5.48M
Other net income (expense)
-247.41%-164.8M
-101.32%-1.47M
100.57%354K
-969.55%-108.13M
-211.67%-55.48M
550.81%111.8M
122.32%111.34M
-460.39%-61.66M
112.19%12.44M
396.81%49.68M
Gain on sale of security
-254.44%-168.8M
-103.08%-3.41M
99.79%-128K
-1,002.54%-109.99M
-211.49%-55.19M
487.59%109.3M
136.82%110.41M
-707.71%-61.82M
111.53%12.19M
139.10%49.51M
Special income (charges)
----
----
--0
--0
---970K
---4.42M
---4.42M
--0
--0
--0
-Less:Impairment of capital assets
----
----
--0
--0
--970K
--4.42M
--4.42M
--0
--0
--0
-Write off
----
----
----
----
----
--4.42M
----
----
----
----
Other non- operating income (expenses)
60.00%4M
4.19%969K
201.25%482K
652.02%1.87M
288.64%684K
-26.47%2.5M
-73.12%930K
-97.69%160K
-93.31%248K
101.64%176K
Income before tax
-78.75%-282.6M
-148.34%-19.6M
67.68%-39.07M
-594.48%-124.8M
-65.80%-99.13M
69.61%-158.1M
127.60%40.54M
-93.43%-120.89M
90.96%-17.97M
46.60%-59.79M
Income tax
-24.87%14.2M
-21.20%11.22M
-86.11%616K
157.52%582K
35,620.00%1.79M
1,094.74%18.9M
801.18%14.23M
1,639.93%4.44M
-22.07%226K
-96.09%5K
Net income
-67.68%-296.8M
-217.12%-30.82M
68.33%-39.69M
-589.05%-125.38M
-68.78%-100.92M
65.85%-177M
118.16%26.31M
-101.46%-125.32M
90.86%-18.2M
46.66%-59.79M
Net income continuous Operations
-67.68%-296.8M
-217.12%-30.82M
68.33%-39.69M
-589.05%-125.38M
-68.78%-100.92M
65.85%-177M
118.16%26.31M
-101.46%-125.32M
90.86%-18.2M
46.66%-59.79M
Minority interest income
Net income attributable to the parent company
-67.68%-296.8M
-217.12%-30.82M
68.33%-39.69M
-589.05%-125.38M
-68.78%-100.92M
65.85%-177M
118.16%26.31M
-101.46%-125.32M
90.86%-18.2M
46.66%-59.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-67.68%-296.8M
-217.12%-30.82M
68.33%-39.69M
-589.05%-125.38M
-68.78%-100.92M
65.85%-177M
118.16%26.31M
-101.46%-125.32M
90.86%-18.2M
46.66%-59.79M
Basic earnings per share
-68.75%-1.62
-214.29%-0.16
67.65%-0.22
-580.00%-0.68
-68.75%-0.54
67.35%-0.96
117.50%0.14
-112.50%-0.68
91.23%-0.1
52.94%-0.32
Diluted earnings per share
-68.75%-1.62
-214.29%-0.16
67.65%-0.22
-580.00%-0.68
-68.75%-0.54
67.35%-0.96
117.50%0.14
-112.50%-0.68
91.23%-0.1
52.94%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 64.02%1.03B64.21%306.38M69.99%272.33M36.74%255.06M107.52%195.05M120.03%627.3M134.93%186.58M66.86%160.21M154.36%186.52M158.67%93.99M
Operating revenue 65.64%1.03B64.34%306.19M70.28%272.31M38.54%255.06M115.04%194.96M117.89%621M134.48%186.31M66.60%159.92M151.27%184.1M149.90%90.66M
Cost of revenue 73.96%408.1M66.97%123.46M107.87%115.31M94.23%97.99M30.33%71.34M62.69%234.6M127.96%73.94M27.58%55.47M54.42%50.45M53.71%54.74M
Gross profit 58.09%620.8M62.39%182.92M49.92%157.02M15.43%157.07M215.17%123.71M178.71%392.7M139.74%112.64M99.37%104.74M234.67%136.07M5,329.05%39.25M
Operating expense 7.85%757.3M6.03%203.52M14.50%200.48M0.51%178.95M10.97%174.36M4.96%702.2M-24.86%191.95M20.85%175.09M23.36%178.04M26.36%157.12M
Selling and administrative expenses 20.15%341.6M21.68%101.19M9.75%87.33M23.28%80.65M28.99%72.43M41.44%284.3M33.15%83.16M61.72%79.57M33.01%65.42M39.82%56.15M
-Selling and marketing expense 39.53%205.8M31.11%64.17M18.83%52.61M59.84%48.05M69.13%40.97M56.58%147.5M45.15%48.94M109.83%44.27M40.29%30.06M34.92%24.22M
-General and administrative expense -0.73%135.8M8.19%37.02M-1.64%34.72M-7.80%32.59M-1.46%31.46M28.09%136.8M19.07%34.22M25.60%35.3M27.38%35.35M43.79%31.93M
Research and development costs 0.29%414.7M-2.93%101.33M18.45%113.15M-12.72%98.3M0.95%101.92M8.19%413.5M-1.21%104.39M-0.35%95.52M17.57%112.63M18.94%100.96M
Other operating expenses -77.27%1M-----------------94.87%4.4M-100.64%-563K-73.86%-306K34.58%-420K13.24%-616K
Operating profit 55.90%-136.5M74.02%-20.6M38.24%-43.45M47.87%-21.88M57.03%-50.65M41.39%-309.5M61.96%-79.31M23.81%-70.36M59.52%-41.97M4.65%-117.86M
Net non-operating interest income expense -52.78%18.7M-71.00%2.47M-63.82%4.03M-54.94%5.21M-16.68%7M21.10%39.6M-25.90%8.51M-12.70%11.13M69.45%11.57M411.27%8.4M
Non-operating interest income -34.48%40.1M-41.76%7.95M-41.91%9.66M-38.81%10.43M-13.08%12.06M12.29%61.2M-21.17%13.65M-9.72%16.63M41.96%17.05M105.33%13.87M
Non-operating interest expense -0.93%21.4M6.70%5.48M2.40%5.64M-4.78%5.22M-7.56%5.06M-0.92%21.6M-11.83%5.14M-3.03%5.5M5.77%5.48M7.08%5.48M
Other net income (expense) -247.41%-164.8M-101.32%-1.47M100.57%354K-969.55%-108.13M-211.67%-55.48M550.81%111.8M122.32%111.34M-460.39%-61.66M112.19%12.44M396.81%49.68M
Gain on sale of security -254.44%-168.8M-103.08%-3.41M99.79%-128K-1,002.54%-109.99M-211.49%-55.19M487.59%109.3M136.82%110.41M-707.71%-61.82M111.53%12.19M139.10%49.51M
Special income (charges) ----------0--0---970K---4.42M---4.42M--0--0--0
-Less:Impairment of capital assets ----------0--0--970K--4.42M--4.42M--0--0--0
-Write off ----------------------4.42M----------------
Other non- operating income (expenses) 60.00%4M4.19%969K201.25%482K652.02%1.87M288.64%684K-26.47%2.5M-73.12%930K-97.69%160K-93.31%248K101.64%176K
Income before tax -78.75%-282.6M-148.34%-19.6M67.68%-39.07M-594.48%-124.8M-65.80%-99.13M69.61%-158.1M127.60%40.54M-93.43%-120.89M90.96%-17.97M46.60%-59.79M
Income tax -24.87%14.2M-21.20%11.22M-86.11%616K157.52%582K35,620.00%1.79M1,094.74%18.9M801.18%14.23M1,639.93%4.44M-22.07%226K-96.09%5K
Net income -67.68%-296.8M-217.12%-30.82M68.33%-39.69M-589.05%-125.38M-68.78%-100.92M65.85%-177M118.16%26.31M-101.46%-125.32M90.86%-18.2M46.66%-59.79M
Net income continuous Operations -67.68%-296.8M-217.12%-30.82M68.33%-39.69M-589.05%-125.38M-68.78%-100.92M65.85%-177M118.16%26.31M-101.46%-125.32M90.86%-18.2M46.66%-59.79M
Minority interest income
Net income attributable to the parent company -67.68%-296.8M-217.12%-30.82M68.33%-39.69M-589.05%-125.38M-68.78%-100.92M65.85%-177M118.16%26.31M-101.46%-125.32M90.86%-18.2M46.66%-59.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -67.68%-296.8M-217.12%-30.82M68.33%-39.69M-589.05%-125.38M-68.78%-100.92M65.85%-177M118.16%26.31M-101.46%-125.32M90.86%-18.2M46.66%-59.79M
Basic earnings per share -68.75%-1.62-214.29%-0.1667.65%-0.22-580.00%-0.68-68.75%-0.5467.35%-0.96117.50%0.14-112.50%-0.6891.23%-0.152.94%-0.32
Diluted earnings per share -68.75%-1.62-214.29%-0.1667.65%-0.22-580.00%-0.68-68.75%-0.5467.35%-0.96117.50%0.14-112.50%-0.6891.23%-0.152.94%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More